Chemotherapy in aggressive T-cell non-Hodgkin lymphoma / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 629-629, 2011.
Artículo
en Chino
| WPRIM
| ID: wpr-421646
ABSTRACT
T-cell non-Hodgkin lymphoma is a group disease with unique clinical and pathological features. It is more aggressive and has lower chemotherapy sensitivity than B-cell lymphoma. In recent years, to search for effective treatment, novel agents such as gemcitabine, targeted therapy combined with chemotherapy and high-dose chemotherapy combined with hematopoietic stem cell transplantation are applied in the treatmentof T-cell non-Hodgkin lymphoma. And some progresses are achieved.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS